NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/02/2018
Back to search
Official data from USPTO
BIOACTIVE COLLAGEN PEPTIDES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOACTIVE COLLAGEN PEPTIDES
ST13
US500000078885325Class
5
Filing
78885325
Registration
3456036
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
02/02/2018
Trademark type
Word
Nice classes
5
Filing date
05/17/2006
Registration date
06/24/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2018
Last transaction
02/02/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2007-07-00
First use in commerce
2007-07-00
Drawing code
4
Owner type
09
Owner location
EBERBACH, DE
Examiner
MAHMOUDI, MARIAM
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
GELITA AG
Gelita Health Products USA, Inc.
Representatives
Douglas M. McAllister Lipsitz & McAllister, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
proteins sold as an integral component feature of nutritional supplements
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/02/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/02/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/02/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
01/11/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/24/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/22/2015
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/24/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/24/2014
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/15/2014
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/14/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/14/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2014
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
04/28/2014
ES8R
TEAS SECTION 8 RECEIVED
04/28/2014
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/24/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/21/2008
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/19/2008
IUAA
USE AMENDMENT ACCEPTED
05/19/2008
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/19/2008
IUAF
USE AMENDMENT FILED
05/15/2008
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/15/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2008
GNRT
NON-FINAL ACTION E-MAILED
01/12/2008
CNRT
NON-FINAL ACTION WRITTEN
01/12/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2007
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/18/2007
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/18/2007
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/18/2007
GNFR
FINAL REFUSAL E-MAILED
06/18/2007
CNFR
FINAL REFUSAL WRITTEN
06/18/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/22/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2007
ALIE
ASSIGNED TO LIE
05/22/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2007
GNRT
NON-FINAL ACTION E-MAILED
11/02/2006
CNRT
NON-FINAL ACTION WRITTEN
11/02/2006
DOCK
ASSIGNED TO EXAMINER
10/19/2006
NWAP
NEW APPLICATION ENTERED
05/23/2006
Continuous trademark protection
Get notified about every new filing that threatens BIOACTIVE COLLAGEN PEPTIDES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.